138 related articles for article (PubMed ID: 32764917)
1. Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database.
Kostikas K; Price D; Gutzwiller FS; Jones B; Loefroth E; Clemens A; Fogel R; Jones R; Cao H
Int J Chron Obstruct Pulmon Dis; 2020; 15():1729-1738. PubMed ID: 32764917
[TBL] [Abstract][Full Text] [Related]
2. Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study.
Punekar YS; Wurst K; Shukla A
COPD; 2015 Jun; 12(3):267-75. PubMed ID: 25093809
[TBL] [Abstract][Full Text] [Related]
3. Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease.
Sicras Mainar A; Huerta A; Navarro Artieda R; Monsó E; Landis SH; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2019; 14():2121-2129. PubMed ID: 31571848
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK.
Rothnie KJ; Numbere B; Gelwicks S; Lu Y; Sharma R; Compton C; Ismaila AS; Quint JK
Int J Chron Obstruct Pulmon Dis; 2023; 18():2673-2685. PubMed ID: 38022832
[TBL] [Abstract][Full Text] [Related]
5. COPD exacerbations by disease severity in England.
Merinopoulou E; Raluy-Callado M; Ramagopalan S; MacLachlan S; Khalid JM
Int J Chron Obstruct Pulmon Dis; 2016; 11():697-709. PubMed ID: 27099486
[TBL] [Abstract][Full Text] [Related]
6. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
Chalmers JD; Poole C; Webster S; Tebboth A; Dickinson S; Gayle A
Respir Res; 2018 Apr; 19(1):63. PubMed ID: 29642882
[TBL] [Abstract][Full Text] [Related]
7. Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013.
Oshagbemi OA; Keene SJ; Driessen JHM; Jordan R; Wouters EFM; de Boer A; de Vries F; Franssen FME
Respir Med; 2018 Nov; 144():1-6. PubMed ID: 30366578
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study.
Kern DM; Davis J; Williams SA; Tunceli O; Wu B; Hollis S; Strange C; Trudo F
Respir Res; 2015 Apr; 16(1):52. PubMed ID: 25899176
[TBL] [Abstract][Full Text] [Related]
9. Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study.
Larsson K; Janson C; Ställberg B; Lisspers K; Olsson P; Kostikas K; Gruenberger JB; Gutzwiller FS; Uhde M; Jorgensen L; Johansson G
Int J Chron Obstruct Pulmon Dis; 2019; 14():995-1008. PubMed ID: 31190785
[No Abstract] [Full Text] [Related]
10. Evaluation of exacerbations and blood eosinophils in UK and US COPD populations.
Vogelmeier CF; Kostikas K; Fang J; Tian H; Jones B; Morgan CL; Fogel R; Gutzwiller FS; Cao H
Respir Res; 2019 Aug; 20(1):178. PubMed ID: 31391053
[TBL] [Abstract][Full Text] [Related]
11. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.
Jones RC; Price D; Ryan D; Sims EJ; von Ziegenweidt J; Mascarenhas L; Burden A; Halpin DM; Winter R; Hill S; Kearney M; Holton K; Moger A; Freeman D; Chisholm A; Bateman ED;
Lancet Respir Med; 2014 Apr; 2(4):267-76. PubMed ID: 24717623
[TBL] [Abstract][Full Text] [Related]
12. Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers.
Singer D; Bengtson LGS; Elliott C; Buikema AR; Franchino-Elder J
Int J Chron Obstruct Pulmon Dis; 2020; 15():3239-3250. PubMed ID: 33324047
[TBL] [Abstract][Full Text] [Related]
13. Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study.
Whittaker H; Rubino A; Müllerová H; Morris T; Varghese P; Xu Y; De Nigris E; Quint JK
Int J Chron Obstruct Pulmon Dis; 2022; 17():427-437. PubMed ID: 35264849
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
[TBL] [Abstract][Full Text] [Related]
15. Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States.
Klinger JR; Wu B; Morland K; Classi P; Fiano R; Grabich S
Respir Med; 2023; 219():107412. PubMed ID: 37729954
[TBL] [Abstract][Full Text] [Related]
16. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
17. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
Johansson G; Mushnikov V; Bäckström T; Engström A; Khalid JM; Wall J; Hoti F
BMC Pulm Med; 2018 Jan; 18(1):17. PubMed ID: 29370846
[TBL] [Abstract][Full Text] [Related]
18. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
[TBL] [Abstract][Full Text] [Related]
19. Differences in COPD Exacerbation Risk Between Women and Men: Analysis From the UK Clinical Practice Research Datalink Data.
Stolz D; Kostikas K; Loefroth E; Fogel R; Gutzwiller FS; Conti V; Cao H; Clemens A
Chest; 2019 Oct; 156(4):674-684. PubMed ID: 31103696
[TBL] [Abstract][Full Text] [Related]
20. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
